Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 3/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | NPC1 | O15118 | 3/20 | 0.33 |
| ▸ | RAB9A | P51151 | 3/20 | 0.33 |
| ▸ | ACACB | O00763 | 3/20 | 0.33 |
| ▸ | HPGD | P15428 | 3/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.33 |
| ▸ | LTA4H | P09960 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.32 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 3/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4924806 | 0.88 | CYP2D6 (0.46) | CYP2D6SMN1; SMN2KDM4EALDH1A1NPC1 | |
| SCHEMBL4201803 | 0.86 | CYP2D6 (0.41) | CYP2D6SMN1; SMN2KDM4EALDH1A1NPC1 | |
| SCHEMBL28717776 | 0.84 | NR5A1 (0.42) | CYP2D6SMN1; SMN2KDM4EALDH1A1NPC1 | |
| SCHEMBL3662611 | 0.84 | NR5A1 (0.42) | CYP2D6SMN1; SMN2KDM4EALDH1A1NPC1 | |
| SCHEMBL436762 | 0.79 | — | — | |
| SCHEMBL4280446 | 0.77 | NPC1 (0.46) | CYP2D6SMN1; SMN2KDM4EALDH1A1NPC1 | |
| Iodide SCHEMBL29457290 | 0.77 | NQO1 (0.38) | SMN1; SMN2ACACBCYP1A2MAPK1HSP90AA1 | |
| SCHEMBL27621001 | 0.75 | ALDH1A1 (0.39) | ALDH1A1GAAMAPK1HSP90AA1KMT2A | |
| SCHEMBL16671916 | 0.73 | KDM4E (0.32) | KDM4EGAAMAPTHSP90AA1MEN1 | |
| SCHEMBL15677660 | 0.73 | RXRA (0.37) | SMN1; SMN2ALDH1A1NPC1RAB9AACACB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116110513-A | Molecular design method and application of triazine desulfurizing agent | 中国石油化工股份有限公司 | 2023-05-12 | — | — | CN | disclosed |
| CN-116099330-A | Method for absorbing hydrogen sulfide gas by using triazine compound | 中国石油化工股份有限公司 | 2023-05-12 | — | — | CN | disclosed |
| WO-2022131284-A1 | FLAME RETARDANT AGENT COMPOSITION, FLAME-RETARDANT RESIN COMPOSITION, AND MOLDED BODY | 株式会社ADEKA | 2022-06-23 | — | — | WO | disclosed |
| WO-2021153414-A1 | THERMOPLASTIC POLYESTER RESIN COMPOSITION AND MOLDED ARTICLE | 東レ株式会社 | 2021-08-05 | — | — | WO | disclosed |
| CN-109400543-A | Triazine precursor, method for preparing triazine precursor and application of triazine precursor | 暨南国际大学 | 2019-03-01 | — | — | CN | disclosed |
| CN-104662066-B | The manufacturing method of polyrotaxane | 住友精化株式会社 | 2018-05-18 | — | — | CN | disclosed |
| US-20080200475-A1 | 4-Piperazinothieno[2,3-D] Pyrimidine Compounds As Platelet Aggregation Inhibitors | PFIZER INC. | 2008-08-21 | — | — | US | disclosed |
| EP-1866317-A1 | 4-PIPERAZINOTHIENO [2, 3-D] PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS | Pharmacia & Upjohn Company LLC (US) | 2007-12-19 | — | — | EP | disclosed |
| WO-2006103555-A1 | 4-PIPERAZINOTHIENO [2, 3-D] PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS | PHARMACIA & UPJOHN COMPANY LLC (US) | 2006-10-05 | — | — | WO | disclosed |
| CN-1069644-C | Novel silicone derivatives,their production and use | CHIBA FLOUR MILLING (JP) | 2001-08-15 | — | — | CN | disclosed |
| CN-1145907-A | Novel silicone derivatives,their production and use | CHIBA FLOUR MILLING (JP) | 1997-03-26 | — | — | CN | disclosed |
| US-5047514-A | Bireactive primary disazo dyes containing 1-amino-8-hydroxynaphthalene-3,6 Disulfonic acid as coupling component | CIBA-GEIGY CORPORATION (US) | 1991-09-10 | — | — | US | disclosed |
| US-4713082-A | Process for dyeing or printing textile fibre materials with reactive dye containing vinyl sulfonyl-type group and chloro-triazinyl amino group | CIBA-GEIGY CORPORATION (US) | 1987-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080200475-A1 | 4-Piperazinothieno[2,3-D] Pyrimidine Compounds As Platelet Aggregation Inhibitors | PF4, TBXA2R, P2RY4 | CYP2D6 113/4885SMN1; SMN2 3818/4885KDM4E 2775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.